Therapeutic Solutions International, Inc.

$TSOI Market Cap: $2.817 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$85.32K

TTM

Gross Margin

66.34%

TTM

Net Earnings

-$2.410M

TTM

Current Assets

$498.7K

Q3 2024

Current Liabilities

$1.839M

Q3 2024

Current Ratio

27.13%

Q3 2024

Total Assets

$3.600M

Q3 2024

Total Liabilities

$1.919M

Q3 2024

Book Value

$1.682M

Q3 2024

Cash

$9.233K

Q3 2024

P/E

-1.169

Nov 29, 2024 EST

Free Cash Flow

-$201.5K

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Revenue	$98.99K	$206.8K	$146.0K	$62.68K	$27.50K	$3.480K	$2.850K	$5.010K	$1.910K	$0.00	$0.00	$350.0K	$1.690M	$0.00	$0.00	$0.00	$0.00
YoY Change	-52.12%	41.66%	132.87%	127.93%	690.23%	22.11%	-43.11%	162.3%			-100.0%	-79.29%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Revenue	$98.99K	$206.8K	$146.0K	$62.68K	$27.50K	$3.480K	$2.850K	$5.010K	$1.910K	$0.00	$0.00	$350.0K	$1.690M	$0.00	$0.00	$0.00	$0.00
Cost Of Revenue	$36.77K	$79.44K	$42.54K	$12.79K	$3.020K	$2.160K	$820.00	$1.610K	$3.190K			$0.00	$60.00K	$0.00
Gross Profit	$62.22K	$127.3K	$103.4K	$49.89K	$24.48K	$1.320K	$2.030K	$3.400K	-$1.280K			$350.0K	$1.630M	$0.00
Gross Profit Margin	62.85%	61.58%	70.86%	79.59%	89.02%	37.93%	71.23%	67.86%	-67.02%			100.0%	96.45%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Selling, General & Admin	$1.488M	$1.766M	$1.613M	$1.337M	$1.040M	$1.126M	$861.2K	$1.035M	$569.7K	$310.0K	$830.0K	$2.490M	$1.950M	$10.00K	$1.540M	$90.00K	$20.00K
YoY Change	-15.75%	9.49%	20.6%	28.61%	-7.66%	30.77%	-16.76%	81.62%	83.76%	-62.65%	-66.67%	27.69%	19400.0%	-99.35%	1611.11%	350.0%
% of Gross Profit	2391.59%	1387.08%	1559.67%	2680.86%	4248.2%	85315.91%	42423.15%	30428.82%				711.43%	119.63%
Research & Development	$560.7K	$1.441M	$794.8K	$562.0K	$27.69K	$74.97K	$25.11K	$10.99K
YoY Change	-61.1%	81.33%	41.42%	1929.58%	-63.07%	198.57%	128.48%
% of Gross Profit	901.08%	1131.83%	768.47%	1126.46%	113.11%	5679.55%	1236.95%	323.24%
Depreciation & Amortization	$311.8K	$10.95K	$18.07K	$6.980K	$6.590K				$0.00	$20.00K	$20.00K	$190.0K	$230.0K	$0.00
YoY Change	2748.35%	-39.42%	158.88%	5.92%					-100.0%	0.0%	-89.47%	-17.39%
% of Gross Profit	501.09%	8.6%	17.47%	13.99%	26.92%							54.29%	14.11%
Operating Expenses	$2.049M	$3.207M	$2.408M	$1.899M	$1.068M	$1.201M	$886.3K	$1.046M	$569.7K	$330.0K	$850.0K	$2.790M	$2.670M	$10.00K	$1.540M	$90.00K	$20.00K
YoY Change	-36.12%	33.2%	26.76%	77.91%	-11.11%	35.52%	-15.23%	83.54%	72.62%	-61.18%	-69.53%	4.49%	26600.0%	-99.35%	1611.11%	350.0%
Operating Profit	-$1.986M	-$3.080M	-$2.304M	-$1.850M	-$1.043M	-$1.200M	-$884.3K	-$1.042M	-$570.9K			-$2.440M	-$1.040M	-$10.00K
YoY Change	-35.5%	33.66%	24.59%	77.31%	-13.06%	35.68%	-15.15%	82.54%				134.62%	10300.0%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Interest Expense	-$404.1K	$646.1K	-$656.3K	-$343.6K	-$654.2K	-$667.1K	-$111.2K	-$20.29K	-$1.680K	$0.00	$10.00K	$20.00K	$70.00K	$0.00
YoY Change	-162.55%	-198.44%	91.01%	-47.47%	-1.94%	499.86%	448.1%	1107.74%		-100.0%	-50.0%	-71.43%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$597.1K	$0.00	-$6.720K							$0.00
YoY Change	-100.0%		-100.0%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Pretax Income	-$2.222M	-$3.677M	-$2.961M	-$2.200M	-$1.697M	-$1.867M	-$995.5K	-$1.062M	-$572.6K	-$540.0K	-$840.0K	-$2.010M	-$970.0K	-$10.00K	-$1.540M	-$90.00K	-$20.00K
YoY Change	-39.56%	24.2%	34.58%	29.61%	-9.08%	87.54%	-6.31%	85.54%	6.04%	-35.71%	-58.21%	107.22%	9600.0%	-99.35%	1611.11%	350.0%
Income Tax	$2.250K	$800.00	$800.00										$0.00	$0.00	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$2.170M	-$3.678M	-$2.961M	-$2.200M	-$1.697M	-$1.867M	-$995.5K	-$1.062M	-$586.4K	-$290.0K	-$550.0K	-$810.0K	-$970.0K	-$10.00K	-$1.540M	-$90.00K	-$20.00K
YoY Change	-41.0%	24.19%	34.62%	29.61%	-9.08%	87.54%	-6.31%	81.17%	102.22%	-47.27%	-32.1%	-16.49%	9600.0%	-99.35%	1611.11%	350.0%
Net Earnings / Revenue	-2191.95%	-1778.72%	-2028.95%	-3509.73%	-6172.07%	-53646.84%	-34928.77%	-21206.79%	-30703.66%			-231.43%	-57.4%
Basic Earnings Per Share	$0.00	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	-$1.309K	-$1.151K	-$1.322K	-$2.082K	-$1.279K	-$1.590K	-$1.269K	-$1.477K	-$6.356K	-$2.652K	-$13.90K	-$348.30	-$101.2K	-$13.41K	-$3.559K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Cash & Short-Term Investments	$27.82K	$18.04K	$94.04K	$252.1K	$26.41K	$22.40K	$30.00	$21.91K	$2.180K	$0.00	$10.00K	$40.00K	$90.00K	$0.00	$0.00	$0.00	$50.00K
YoY Change	54.21%	-80.82%	-62.7%	854.75%	17.9%	74566.67%	-99.86%	905.05%		-100.0%	-75.0%	-55.56%				-100.0%
Cash & Equivalents	$27.82K	$18.04K	$94.04K	$252.1K	$26.41K	$22.40K	$30.00	$21.91K	$2.180K	$0.00	$10.00K	$40.00K	$90.00K	$0.00	$0.00	$0.00	$50.00K
Short-Term Investments
Other Short-Term Assets	$16.32K	$223.4K	$969.5K	$87.53K	$105.2K	$113.5K	$1.050K	$14.30K	$213.4K	$190.0K	$120.0K	$30.00K	$530.0K	$0.00	$310.0K	$10.00K
YoY Change	-92.69%	-76.96%	1007.65%	-16.79%	-7.34%	10711.43%	-92.66%	-93.3%	12.34%	58.33%	300.0%	-94.34%		-100.0%	3000.0%
Inventory	$22.57K	$42.43K	$39.82K	$5.400K	$5.180K	$0.00	$1.520K	$36.44K	$29.68K			$30.00K	$50.00K	$0.00
Prepaid Expenses
Receivables	$19.20K	$25.40K	$16.61K	$2.440K	$2.900K			$0.00	$2.180K
Other Receivables	$0.00	$0.00	$0.00	$0.00	$0.00			$0.00	$0.00
Total Short-Term Assets	$85.91K	$309.2K	$1.120M	$347.5K	$139.7K	$135.9K	$2.600K	$72.65K	$247.5K	$190.0K	$130.0K	$100.0K	$660.0K	$0.00	$310.0K	$10.00K	$50.00K
YoY Change	-72.22%	-72.39%	222.28%	148.8%	2.77%	5127.69%	-96.42%	-70.65%	30.26%	46.15%	30.0%	-84.85%		-100.0%	3000.0%	-80.0%
Property, Plant & Equipment	$499.9K	$281.7K	$318.2K	$64.04K					$0.00	$0.00	$70.00K	$90.00K	$10.00K	$0.00
YoY Change	77.47%	-11.48%	396.89%							-100.0%	-22.22%	800.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.120K	$11.66K	$148.5K	$191.9K	$171.3K	$71.01K	$23.93K	$32.23K	$12.48K	$10.00K	$10.00K	$10.00K	$10.00K	$0.00
YoY Change	-64.67%	-92.15%	-22.62%	12.02%	141.26%	196.74%	-25.75%	158.25%	24.8%	0.0%	0.0%	0.0%
Total Long-Term Assets	$3.206M	$3.296M	$595.8K	$256.0K	$171.3K	$71.01K	$23.93K	$32.23K	$12.47K	$10.00K	$80.00K	$100.0K	$2.800M	$0.00	$0.00	$0.00	$0.00
YoY Change	-2.74%	453.28%	132.77%	49.4%	141.26%	196.74%	-25.75%	158.46%	24.7%	-87.5%	-20.0%	-96.43%
Total Assets	$3.292M	$3.606M	$1.716M	$603.5K	$311.0K	$206.9K	$26.53K	$104.9K	$260.0K	$200.0K	$210.0K	$200.0K	$3.460M	$0.00	$310.0K	$10.00K	$50.00K
YoY Change
Accounts Payable	$404.9K	$409.2K	$394.0K	$302.5K	$324.9K	$320.8K	$343.8K	$327.6K	$277.3K	$290.0K	$300.0K	$280.0K	$110.0K	$0.00	$10.00K	$0.00	$10.00K
YoY Change	-1.06%	3.85%	30.27%	-6.91%	1.29%	-6.69%	4.95%	18.12%	-4.37%	-3.33%	7.14%	154.55%		-100.0%		-100.0%
Accrued Expenses	$556.6K	$540.4K	$512.6K	$618.7K	$510.7K	$717.7K	$432.6K	$135.2K	$15.64K	$10.00K	$250.0K	$20.00K	$40.00K	$0.00
YoY Change	3.01%	5.43%	-17.15%	21.15%	-28.85%	65.89%	220.09%	764.19%	56.4%	-96.0%	1150.0%	-50.0%
Deferred Revenue
YoY Change
Short-Term Debt	$752.4K	$1.054M	$1.044M	$981.4K	$38.48K	$45.78K	$27.46K	$0.00	$0.00	$30.00K	$240.0K	$0.00	$0.00	$0.00	$0.00	$10.00K	$0.00
YoY Change	-28.61%	0.9%	6.42%	2450.52%	-15.95%	66.72%			-100.0%	-87.5%					-100.0%
Long-Term Debt Due	$4.640K	$4.640K	$4.070K		$937.5K	$458.5K	$429.2K	$221.5K	$196.0K			$30.00K	$3.000M	$10.00K
YoY Change	0.0%	14.0%			104.48%	6.82%	93.81%	12.98%				-99.0%	29900.0%
Total Short-Term Liabilities	$1.900M	$2.210M	$2.496M	$2.347M	$2.346M	$2.017M	$1.341M	$684.2K	$489.0K	$330.0K	$790.0K	$330.0K	$3.160M	$10.00K	$10.00K	$10.00K	$10.00K
YoY Change	-14.06%	-11.46%	6.35%	0.06%	16.29%	50.45%	95.97%	39.92%	48.18%	-58.23%	139.39%	-89.56%	31500.0%	0.0%	0.0%	0.0%
Long-Term Debt	$5.510K	$10.51K	$15.53K	$0.00	$0.00	$0.00	$0.00	$75.50K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	-47.57%	-32.32%					-100.0%
Other Long-Term Liabilities	$105.0K	$0.00	$8.810K	$34.18K								$60.00K	$0.00
YoY Change		-100.0%	-74.22%
Total Long-Term Liabilities	$110.5K	$10.51K	$24.34K	$34.18K	$0.00	$0.00	$0.00	$75.50K	$0.00	$0.00	$0.00	$60.00K	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	951.76%	-56.82%	-28.79%				-100.0%				-100.0%
Total Liabilities	$2.167M	$2.221M	$2.521M	$2.382M	$2.346M	$2.017M	$1.341M	$759.7K	$489.0K	$330.0K	$790.0K	$390.0K	$3.160M	$10.00K	$10.00K	$10.00K	$10.00K
YoY Change	-2.43%	-11.9%	5.84%	1.51%	16.29%	50.45%	76.5%	55.36%	48.18%	-58.23%	102.56%	-87.66%	31500.0%	0.0%	0.0%	0.0%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021
Basic Shares Outstanding	3.169B shares	2.528B shares	2.263B shares
Diluted Shares Outstanding	3.169B shares	2.528B shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $2.8175 Million

About THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

Therapeutic Solutions International, Inc. engages in the provision of immune modulation for the treatment of several specific diseases. The company is headquartered in Elk City, Idaho and currently employs 3 full-time employees. The company went IPO on 2008-06-09. The firm is developing a range of immune-modulatory agents to target certain cancers, schizophrenia, suicidal ideation, and traumatic brain injury (TBI), and for daily health. Its flagship product, QuadraMune, is a multi-patented synergistic blend of pterostilbene, sulforaphane, epigallocatechin gallate, and thymoquinone. Its synergistic blend of ingredients helps the immune system fight off common and complex ailments and promotes healthy T Cell activity. The company has developed an allogenic version of StemVacs and has filed patents to cover activating universal donor immune system cells called dendritic cells in a manner so that upon injection they reprogram the body's natural killer (NK) cells. The company has obtained exclusive rights to a patented adult stem cell for development of therapeutics in the area of chronic traumatic encephalopathy (CTE), TBI, and lung pathology.

Industry: Surgical & Medical Instruments & Apparatus Peers: